Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Interim results reported from phase I/IIa ensituximab trial

Jan. 24, 2012

MEK-162 investigated in biliary tract cancer

Jan. 23, 2012

Traditional medicine ameliorates chemotherapy-induced nausea and vomiting

Jan. 23, 2012

Everolimus improves survival of patients with gastrointestinal cancer

Jan. 23, 2012

Chilean team presents new biomarker of gastric cancer progression

Jan. 20, 2012

MLN-8237 investigated with cisplatin in gastrointestinal cancer models

Jan. 20, 2012

Therapeutic investigation of dacomitinib expands to gastric cancer

Jan. 20, 2012

Tesetaxel is active in patients with gastroesophageal cancer

Jan. 20, 2012

BKM-120 assessed as monotherapy and in combination regimens in metastatic breast cancer

Jan. 11, 2012

New Evestra progesterone receptor inhibitor shows potential as breast cancer therapy

Jan. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...